All terms in GO
| Label | Id | Description |
|---|---|---|
| signal sequence binding | GO_0005048 |
Binding to a signal sequence, a specific peptide sequence found on protein precursors or mature proteins that dictates where the mature protein is localized.
|
| peptide binding | GO_0042277 |
Binding to a peptide, an organic compound comprising two or more amino acids linked by peptide bonds.
|
| positive regulation of cell migration in another organism | GO_0044623 |
Any process that activates or increases the frequency, rate or extent of cell migration in a second organism.
|
| modulation of cell migration in another organism | GO_0044621 |
The process in which an organism effects a change in the process of cell migration in a second organism.
|
| positive regulation of cell migration | GO_0030335 |
Any process that activates or increases the frequency, rate or extent of cell migration.
|
| nuclear export signal receptor activity | GO_0005049 |
Combining with a nuclear export signal (NES) on a cargo to be transported, to mediate transport of a the cargo through the nuclear pore, from the nuclear lumen to the cytoplasm. The cargo can be either a RNA or a protein.
|
| nucleocytoplasmic carrier activity | GO_0140142 |
Binding to and carrying a cargo between the nucleus and the cytoplasm by moving along with the cargo. The cargo can be either a RNA or a protein.
|
| envenomation resulting in modulation of cell migration in another organism | GO_0044624 |
A process that begins with venom being forced into an organism by the bite or sting of another organism, and ends with the modulation of cell migration in the bitten organism.
|
| envenomation resulting in negative regulation of cell migration in another organism | GO_0044625 |
A process that begins with venom being forced into an organism by the bite or sting of another organism, and ends with the negative regulation of cell migration in the bitten organism.
|
| envenomation resulting in positive regulation of cell migration in another organism | GO_0044626 |
A process that begins with venom being forced into an organism by the bite or sting of another organism, and ends with the positive regulation of cell migration in the bitten organism.
|
| modulation of complement activation, classical pathway in another organism | GO_0044627 |
A process that modulates the frequency, rate or extent of the classical pathway of complement activation, in a different organism.
|
| regulation of complement activation, classical pathway | GO_0030450 |
Any process that modulates the frequency, rate or extent of the classical pathway of complement activation.
|
| positive regulation of complement activation, classical pathway in another organism | GO_0044628 |
Any process that activates or increases the frequency, rate or extent of complement activation by the classical pathway, in a different organism.
|
| positive regulation of complement activation, classical pathway | GO_0045960 |
Any process that activates or increases the frequency, rate or extent of complement activation by the classical pathway.
|
| pyrimidine deoxyribonucleoside interconversion | GO_0019690 |
The chemical reactions and pathways by which a pyrimidine deoxyribonucleoside is synthesized from another deoxyribopyrimidine nucleoside.
|
| pyrimidine deoxyribonucleoside metabolic process | GO_0046125 |
The chemical reactions and pathways involving any one of a family of organic molecules consisting of a pyrimidine base covalently bonded to a sugar deoxyribose (a deoxyribonucleoside).
|
| pyrimidine nucleoside interconversion | GO_0019689 |
The chemical reactions and pathways by which a pyrimidine nucleoside is synthesized from another pyrimidine nucleoside.
|
| negative regulation of complement activation, classical pathway in another organism | GO_0044629 |
Any process that stops, prevents, or reduces the frequency, rate or extent of complement activation by the classical pathway, in a different organism.
|
| negative regulation of complement activation, classical pathway | GO_0045959 |
Any process that stops, prevents, or reduces the frequency, rate or extent of complement activation by the classical pathway.
|
| GO_0019691 | GO_0019691 |